Peter Tippett | |
|---|---|
 | |
| Born | Peter S. Tippett 1953 (age 70–71) Dearborn, Michigan, U.S. |
| Nationality | American |
| Education | Kalamazoo College, B.A., Biology (1975); Rockefeller University, Research Assistant to Nobel Prize winner Robert Bruce Merrifield (1975-1976); Case Western Reserve University, Ph.D. in Biochemistry (1981); Case Western Reserve University, Doctor of Medicine (1983); American Board of Internal Medicine, Diplomate Certified, Internal Medicine (1987) |
| Medical career | |
| Profession | Medicine |
| Field | Internal Medicine |
| Institutions | Case Western Reserve University Department of Biochemistry; The Pacific Foundation for the Advancement of Science and Medicine; Cleveland Metropolitan General Hospital; Euclid Hospital; Daniel Freeman Marina Hospital |
| Sub-specialties | Biochemistry |
| Research | Solid Phase Peptide Synthesis of Immunoglobulin Hypervariable Regions; Synthesis of Smallest Active Complement Peptides from C3 and C5; Hepatic Glucokinase -- Kinetics, Regulation, and Turnover; Palmitoyl CoA's Role as a Metabolic Effector; Protein-lipid Interactions; Measurement of Critical Micelle Concentrations; Hypomagnesemia, Meperidine Related Seizures in Renal Failure; Cardiologic Effect of Heat Stroke. |
Peter S. Tippett (born 1953) is an American physician, researcher, and inventor known for contributions to information security, clinical medicine, and technology. These contributions include the development of the anti-virus program "Corporate Vaccine".[1] Tippett was Vice President of Verizon's Innovations Incubator and Chief Medical Officer for Verizon Enterprise Services from 2009 to 2015. He is currently the Founder and CEO of careMESH Inc.[2]
- ^ "PC Mag". 1989-04-25.
- ^ "careMESH". careMESH. Archived from the original on 2020-04-29. Retrieved 2020-04-23.